Your browser doesn't support javascript.
loading
HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer.
Khelwatty, Said A; Puvanenthiran, Soozana; Essapen, Sharadah; Bagwan, Izhar; Seddon, Alan M; Modjtahedi, Helmout.
Afiliação
  • Khelwatty SA; School of Life Science, Pharmacy and Chemistry, Kingston University London, London KT1 2EE, UK.
  • Puvanenthiran S; School of Life Science, Pharmacy and Chemistry, Kingston University London, London KT1 2EE, UK.
  • Essapen S; School of Life Science, Pharmacy and Chemistry, Kingston University London, London KT1 2EE, UK.
  • Bagwan I; St Luke's Cancer Centre, Royal Surrey County Hospital, Guildford GU2 7XX, UK.
  • Seddon AM; Department of Histopathology, Royal Surrey County Hospital, Guildford GU2 7XX, UK.
  • Modjtahedi H; School of Life Science, Pharmacy and Chemistry, Kingston University London, London KT1 2EE, UK.
Cancers (Basel) ; 13(4)2021 Feb 05.
Article em En | MEDLINE | ID: mdl-33562755
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article